sickle cell disease
Who Will Pay for Sickle Cell Gene Therapy?
The December 2023 FDA approval of the first two gene therapies to treat sickle cell disease was a giant step ...
MARCH 22, 2024
For Sickle Cell Patients, the Struggle Continues
CHICAGO—Kevin Wake understands all too well the disparities in healthcare that prevail in the United States, ...
SEPTEMBER 7, 2022
New Sickle Cell Disease Pain Recommendations Stress Individualized Interdisciplinary Care
People living with chronic pain due to sickle cell disease should be managed with a variety of pharmacologic and ...
AUGUST 13, 2020
FDA Approves Adakveo for Painful Complication of Sickle Cell Disease
The FDA approved crizanlizumab-tmca for sickle cell patients 16 and older who suffer vaso-occlusive crisis, a ...
NOVEMBER 19, 2019
Oral L-Glutamine Reduces Acute Pain, Hospitalizations in Sickle Cell Patients
For children and adults with sickle cell anemia, pharmaceutical-grade L-glutamine oral therapy alleviates acute ...
NOVEMBER 16, 2018
